# Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult Females

> **NCT05309525** · PHASE4 · COMPLETED · sponsor: **Luxurgery** · enrollment: 17 (actual)

## Conditions studied

- Cellulite

## Interventions

- **DRUG:** Collagenase Clostridium Histolyticum-Aaes
- **DRUG:** Lysteda 650 MG Oral Tablet

## Key facts

- **NCT ID:** NCT05309525
- **Lead sponsor:** Luxurgery
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-22
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309525, "Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult Females". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05309525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*